Scleroderma: Cyclophosphamide or Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Keith M. Sullivan, MD
Duke University
Study Chair - Leslie J. Crofford, MD
University of Kentucky, Women's Health Program: Rheumatology
Principal Investigator - Maureen D. Mayes, MD, MPH
University of Texas - Houston Health Science Center
Principal Investigator - Peter A. McSweeney, MD
Presbyterian/St. Luke's Medical Center:Rocky Mountain Cancer Center
Study Chair - Richard A. Nash, MD
Fred Hutchinson Cancer Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- Dr. Markland Medical Professional Corporation
Saskatoon, Saskatchewan, Canada
- City of Hope National Medical Center
Duarte, California, United States
- Ucla Medical School
Los Angeles, California, United States
- University of Kentucky
Lexington, Kentucky, United States
- Boston University School of Medicine
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of Toledo Health Science Campus
Toledo, Ohio, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Texas-Houston Medical School
Houston, Texas, United States
- Fred Hutchinson Cancer Research Center (fhcrc)
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2005
- Primary completion
- 30 Apr 2016
- Completion
- 30 Apr 2016
- Last update posted
- 12 Apr 2023
- Registered enrollment
- 75
- Registry id
- NCT00114530
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.